Clinical trial
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for…
NCT00319657 · Stanford University, Other · Active, not recruiting
Key facts
| NCT number | NCT00319657 |
|---|---|
| Title | Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs |
| Official title | Total Lymphoid Irradiation, Anti-Thymocyte Globulin and Purified Donor CD34+ and T-Cell Transfusion in HLA-Matched Living Donor Kidney Transplantation |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Immune Tolerance |
| Intervention type | Biological, Radiation |
| Interventions | Hematopoietic cell transplantation, Total lymphoid irradiation |
| Enrollment | 15 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2026 |
| Completion | Jul 1, 2026 |
| First posted | Apr 27, 2006 |
| Last update posted | Jun 18, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: